1. 上海中医药大学附属龙华医院特需病房,上海,200032
2. 上海中医药大学研究生院,上海,201203
3. 上海中医药大学基础医学院,上海,201203
扫 描 看 全 文
安世英, 赵文清, 郑敏宇, 等. 加味下瘀血汤联合乙酰半胱氨酸治疗间质性肺纤维化的临床研究[J]. 上海中医药杂志, 2017,51(9):57-59.
AN Shi-ying, ZHAO Wen-qing, ZHENG Min-yu, et al. Clinical study of Modified Xiayuxue Decoction combined with acetylcysteine in the treatment of interstitial pulmonary fibrosis[J]. Shanghai Journal of Traditional Chinese Medicine, 2017,51(9):57-59.
安世英, 赵文清, 郑敏宇, 等. 加味下瘀血汤联合乙酰半胱氨酸治疗间质性肺纤维化的临床研究[J]. 上海中医药杂志, 2017,51(9):57-59. DOI:
AN Shi-ying, ZHAO Wen-qing, ZHENG Min-yu, et al. Clinical study of Modified Xiayuxue Decoction combined with acetylcysteine in the treatment of interstitial pulmonary fibrosis[J]. Shanghai Journal of Traditional Chinese Medicine, 2017,51(9):57-59. DOI:
目的:观察加味下瘀血汤联合乙酰半胱氨酸对间质性肺纤维化的影响。 方法:将60例间质性肺纤维化患者随机分为治疗组和对照组,每组30例。治疗组予加味下瘀血汤联合乙酰半胱氨酸治疗,对照组予乙酰半胱氨酸治疗。两组治疗周期均为6个月,观察中医证候积分、肺功能指标、6分钟步行距离、生活质量评分、HRCT评分的变化情况。 结果:①两组治疗后,中医证候积分、生活质量积分均较治疗前减少,6分钟步行距离较治疗前增加,差异有统计学意义(P<0.05);组间治疗后比较,中医证候积分、生活质量积分和6分钟步行距离差异均有统计学意义(P<0.05)。②治疗后,治疗组DLCO·SB值升高(P<0.05),对照组肺功能各指标均无明显变化(P>0.05);组间治疗后比较,治疗组DLCO·SB值高于对照组(P<0.05)。③两组治疗前后组内及组间治疗后比较,HRCT积分差异均无统计学意义(P<0.05)。 结论:加味下瘀血汤联合乙酰半胱氨酸治疗间质性肺纤维化,可改善患者的中医证候和肺泡弥散功能,提高运动耐力和生活质量,阻止肺部纤维化病灶进展。
Objective:To observe the effects of Modified Xiayuxue Decoction combined with acetylcysteine on interstitial pulmonary fibrosis. Methods60 patients with interstitial pulmonary fibrosis were randomly divided into the treatment group and control group,30 cases in each group. The treatment group was treated with Modified Xiayuxue Decoction combined with acetylcysteine,and the control group was treated with acetylcysteine,with a course of 6 months. The TCM syndrome score,pulmonary function indexes,6-minute walk distance,St. Georges respiratory questionnaire(SGRQ)score for life quality evaluation and high resolution CT(HRCT)score were observed and compared. Results:①Compared with treatment before,the TCM syndrome score and SGRQ score were decreased and 6-minute walk distance was increased in both groups after treatment,with statistical differences(P<0.05).There were statistically significant differences on the TCM syndrome score,SGRQ score and 6-minute walk distance between the two groups after treatment(P<0.05). ②After treatment,the diffusing capacity for carbon monoxide of single breath(DLCO·SB)in the treatment group was increased(P<0.05),but there were no obviously changes of all pulmonary function indexes in the control group(P>0.05). The DLCO·SB in the treatment group was higher than that in the control group after treatment(P<0.05). ③For the comparison between treatment before and after within group or between the two groups after treatment,there was no statistically significant difference on HRCT score. Conclusion:Modified Xiayuxue Decoction combined with acetylcysteine can be used in the treatment of interstitial pulmonary fibrosis,which can improve the TCM syndrome and alveolar diffusion function of patients,enhance the exercise tolerance and life quality,and prevent the progression of pulmonary fibrosis.
间质性肺纤维化中西医结合疗法加味下瘀血汤
interstitial pulmonary fibrosistherapy of integrated Chinese and western medicineModified Xiayuxue Decoction
0
浏览量
192
下载量
0
CSCD
19
CNKI被引量
关联资源
相关文章
相关作者
相关机构